JNJ Stock Recent News
JNJ LATEST HEADLINES
Looking for long-term stocks to buy for decades of gains requires a strategy focusing on stable, established companies with proven track records. The key to selecting long-term stocks to buy to build generational wealth is identifying companies with strong fundamentals, competitive advantages, and financial stability over time.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
Five stocks to focus with recent dividend hike are: JNJ, TRV, SON, KBH, SPFI.
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The World Health Organization is likely to issue a wider warning about contaminated Johnson and Johnson-made children's cough syrup found in Nigeria last week, it said in an email.
Johnson & Johnson (NYSE: JNJ) recently reported its Q1 results, with revenues marginally below but earnings exceeding our estimates. The company reported revenue of $21.4 billion and adjusted earnings of $2.71 per share, compared to our estimates of $21.5 billion and $2.68, respectively.
A Florida jury on Thursday concluded that Johnson & Johnson's baby powder talc product did not cause the ovarian cancer of a Florida woman who died in 2019.
Johnson & Johnson (JNJ) continued with its long streak of earnings beat but lagged revenue estimates.
The healthcare titan unveiled its first set of quarterly results for 2024. It missed slightly on the top line but beat on profitability.